Pharmafile Logo

New appointments in our UK and New York offices

Research Partnership is delighted to announce various appointments across our offices. Ella Buckland joins as Research Executive, Ines Belchior joins as Research Analyst, and Emma Warburton joins as Business Development Executive, all three to be based in the UK headquarters. Aaron Platt joined as Senior Research Executive and Dominika Klubek joined as Research Manager, both within the MedTech team and Austin Andrews joined as Research Analyst – they will reside in the New York office…

Ella, who studied Chemistry at the University of Bath, has experience working in market research across a range of immunology diseases, specifically in dermatology. Ines has previous experience conducting social and market research in a communications and strategy consultancy. She studied International Politics at City, University of London.
Emma has previous experience working as a pricing and market research analyst. She studied global health and received a master’s degree in international health policy from London School of Economics.

Austin Andrews attended Bucknell University in Pennsylvania where he got his B.A. in Biology and Psychology.

Aaron Platt received his undergraduate degree in sociology from New York University and his master’s degree in sociology from the University of California, Berkeley, where he is also currently working on his doctoral dissertation. He has worked in social science research, both quantitative and qualitative, for 11 years, working on projects for pharmaceutical and healthcare-related non-profit organisations.

Dominika has previous experience in leading primarily quant studies across a broad range of industries from consumer health to CPG and retail. She worked at Lieberman Research for 5 years with a strong focus in pharmaceuticals. Dominika has her master’s degree in industrial and organizational psychology from Hofstra University in Long Island.

Jon Ford has joined the London headquarters as in-house Recruitment Consultant, a newly created role to support demand for additional talent. He previously spent 4 years at Trace Recruitment where he focused on head hunting and recruitment in the Market Research and Brand Strategy sectors.

Speaking about the new appointments, Founding Director Mary Assimakopoulos said, “We are delighted to welcome our new hires and look forward to making further recruitment announcements in the near future .”

Find out more about a career with us »

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Free Thinking: Behavioural economics

Our Free Thinking white paper asks, does behavioural economic theory have a role to play in pharmaceutical market research?

Article: The Colombia Conundrum

Published in eye for pharma 30 January by Marc Yates

Ageing in China: The Implications for Healthcare

Published in eye for pharma 12 December by Marc Yates

Exploring MINT: Part 4 – Turkey

In the fourth and final of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in...

Getting to grips with Russia’s healthcare market

As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...

Exploring MINT: Part 3 – Nigeria

In the third of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Nigeria.

Exploring MINT: Part 2 – Indonesia

In the second of a series of posts focusing on each of the ‘MINT’ markets, I take an in-depth look at the opportunities and challenges for pharma in Indonesia, with...

Free Thinking: Leveraging the ASEAN Market

If you can only research one ASEAN market, which one do you choose?Our Free Thinking paper investigates the opportunities for pharma in ASEAN and outlines the factors you need to...

Free Thinking: Biosimilars: Friend or foe to healthcare?

Our Free Thinking white paper looks at the opportunities for biosimilars and the threats to innovator biologics.